Skip to content

Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: a randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504817-56-00
Acronym
2022.0100
Enrollment
560
Registered
2023-06-27
Start date
2023-09-05
Completion date
Unknown
Last updated
2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, Lower respiratory tract infection, Viral wheeze / bronchial hyperreactivity

Brief summary

the time from admission to meeting all discharge criteria

Detailed description

Length of stay, Number of PICU admissions, Time spent on oxygen therapy, Duration of symptoms, Time from admission to return to normal health, Time from admission to return to school/day care, Unscheduled health care visits after discharge during follow-up, Patient Quality of Life, Parental anxiety, Overall pediatric health, Economic evaluation, Reasons for starting oxygen therapy

Interventions

DRUGConoxia Liquid
DRUGvloeibaar gemaakt.

Sponsors

Spaarne Gasthuis
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
the time from admission to meeting all discharge criteria

Secondary

MeasureTime frame
Length of stay, Number of PICU admissions, Time spent on oxygen therapy, Duration of symptoms, Time from admission to return to normal health, Time from admission to return to school/day care, Unscheduled health care visits after discharge during follow-up, Patient Quality of Life, Parental anxiety, Overall pediatric health, Economic evaluation, Reasons for starting oxygen therapy

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026